Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort
Posted innews OB/GYN & Women's Health Otorhinolaryngology

Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort

This study investigates the association between peri- and post-menopausal hormone replacement therapy (HRT) and the risk of voice disorders, revealing transiently increased dysphonia risk within the first nine months but no sustained clinical impact after one year.